PL434249A1 - Szczep Enterococcus faecalis do produkcji monoklonalnych preparatów fagowych - Google Patents

Szczep Enterococcus faecalis do produkcji monoklonalnych preparatów fagowych

Info

Publication number
PL434249A1
PL434249A1 PL434249A PL43424914A PL434249A1 PL 434249 A1 PL434249 A1 PL 434249A1 PL 434249 A PL434249 A PL 434249A PL 43424914 A PL43424914 A PL 43424914A PL 434249 A1 PL434249 A1 PL 434249A1
Authority
PL
Poland
Prior art keywords
production
enterococcus faecalis
monoclonal phage
phage preparations
faecalis strain
Prior art date
Application number
PL434249A
Other languages
English (en)
Other versions
PL241190B1 (pl
Inventor
Małgorzata ŁOBOCKA
Dariusz IZAK
Agnieszka GOZDEK
Jan GAWOR
Robert GROMADKA
Beata WEBER-DĄBROWSKA
Andrzej Górski
Agnieszka Zalewska
Kamil DĄBROWSKI
Original Assignee
Instytut Biochemii I Biofizyki Polskiej Akademii Nauk
Instytut Immunologii I Terapii Doświadczalnej Polskiej Akademii Nauk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Biochemii I Biofizyki Polskiej Akademii Nauk, Instytut Immunologii I Terapii Doświadczalnej Polskiej Akademii Nauk filed Critical Instytut Biochemii I Biofizyki Polskiej Akademii Nauk
Priority to PL434249A priority Critical patent/PL241190B1/pl
Publication of PL434249A1 publication Critical patent/PL434249A1/pl
Publication of PL241190B1 publication Critical patent/PL241190B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02—Recovery or purification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Ujawniono szczep Enterococcus faecalis do otrzymywania monoklonalnych preparatów bakteriofagów litycznych o wysokim mianie, pozbawiony zanieczyszczeń niepożądanymi bakteriofagami, który to szczep gwarantuje produkcję bezpiecznych w stosowaniu preparatów bakteriofagowych nie będących źródłem rozsiewu genów związanych z wirulencją bakterii.
PL434249A 2014-08-31 2014-08-31 Szczep Enterococcus faecalis pozbawiony profagów oraz sposób otrzymywania preparatu bakteriofagowego PL241190B1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL434249A PL241190B1 (pl) 2014-08-31 2014-08-31 Szczep Enterococcus faecalis pozbawiony profagów oraz sposób otrzymywania preparatu bakteriofagowego

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL434249A PL241190B1 (pl) 2014-08-31 2014-08-31 Szczep Enterococcus faecalis pozbawiony profagów oraz sposób otrzymywania preparatu bakteriofagowego

Publications (2)

Publication Number Publication Date
PL434249A1 true PL434249A1 (pl) 2020-10-05
PL241190B1 PL241190B1 (pl) 2022-08-22

Family

ID=72669402

Family Applications (1)

Application Number Title Priority Date Filing Date
PL434249A PL241190B1 (pl) 2014-08-31 2014-08-31 Szczep Enterococcus faecalis pozbawiony profagów oraz sposób otrzymywania preparatu bakteriofagowego

Country Status (1)

Country Link
PL (1) PL241190B1 (pl)

Also Published As

Publication number Publication date
PL241190B1 (pl) 2022-08-22

Similar Documents

Publication Publication Date Title
HK1257074A1 (zh) 溶瘤病毒株
JOP20200192A1 (ar) أجسام مضادة لـ tigit
PH12017500858A1 (en) Mocrocyclic peptides useful as immunomodulators
EA201791216A1 (ru) Иммуномодуляторы
PH12016501763A1 (en) Multispecific antibodies
EA201790695A1 (ru) Иммуномодуляторы
BR112017024123A2 (pt) construtos de expressão e métodos de manipulação por engenharia genética de levedura metilotrófica
EA201791231A1 (ru) Иммуномодуляторы
EA201790265A1 (ru) Способы получения тромбоцит-содержащих продуктов
PH12018550160A1 (en) NEW ANTI-SIRPa ANTIBODIES AND THEIR THERAPEUTIC APPLICATIONS
DK3142785T3 (da) Fremgangsmåde til fremstilling af alkenoler og anvendelse deraf til fremstilling af 1,3-butadien
MX2020007742A (es) Procesos para preparar fluorocetolidos.
PL409332A1 (pl) Szczepy Enterococcus faecalis do produkcji monoklonalnych preparatów fagowych
HK1250381A1 (zh) 使用噬菌體的細菌檢測
PL409330A1 (pl) Szczepy Staphylococcus aureus do produkcji monoklonalnych preparatów fagowych pozbawionych zanieczyszczeń plazmidowym DNA
PL434249A1 (pl) Szczep Enterococcus faecalis do produkcji monoklonalnych preparatów fagowych
PL434248A1 (pl) Szczep Staphylococcus aureus do produkcji monoklonalnych preparatów fagowych pozbawionych zanieczyszczeń plazmidowym DNA
RU2014145033A (ru) Штамм бактерий enterococcus faecium ef79osau, обладающий антагонистической активностью в отношении бактерий рода listeria и вида enterococcus faecalis
ZA201804025B (en) Inactivation of viruses by delipidation
GB2548427B (en) Improved alkene dehydrogenation process
DK3440200T3 (da) Modificeret bakteriofag
TH1601003632A (th) Lactobacillus salivarius สำหรับการรักษาของมาสไตติส
GB201409885D0 (en) The Five Gold Rings (The Absolute Truth)